150322-38-6,
5-(2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one,
5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one,
Desacetylprasugrel,
5-(2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-5,6,7,7a-tetrahydrothieno(3,2-c)pyridin-2(4h)-one,
Prasugrel desacetyl,
Thieno(3,2-C)pyridin-2(4H)-one, 5-(2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-5,6,7,7a-tetrahydro-,
Thieno[3,2-c]pyridin-2(4H)-one, 5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-5,6,7,7a-tetrahydro-,
(R)-Prasugrel Thiolactone,
SCHEMBL253435,
CHEMBL3526430,
SCHEMBL13249023,
UNII-1F19E6097Q,
CTK8B6540,
DTXSID00465251,
MJAMUSZUMAHFLH-UHFFFAOYSA-N,
BCP12275,
EBD26379,
KS-00000PZ6,
ANW-53618,
FD7326,
MFCD00920409,
AKOS015899146,
1F19E6097Q,
ACN-028887,
RL01919,
AC-25298,
AK-88322,
DS-18458,
SC-44442,
AX8229374,
TC-142363,
FT-0687516,
ST24023721,
R95913,
322C386,
J-516602,
I14-12020,
5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-5,,
Prasugrel Metabolite R-95913 (Impurity IV, Mixture of Diastereomers),
5-(alpha-cyclopropylcarbonyl-2-fluorobenzyl)-2-oxo-2,4,5,6,7,7a-hexahydro thieno[3,2-c] pyridine,
5-(alpha-cyclopropylcarbonyl-2-fluorobenzyl)-2-oxo-2,4,5,6,7,7a-hexahydrothieno[3,2-c]pyridine,
5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-5,6,7,7a-tetrahydro-thieno[3,2-c]pyridin-2(4h)-one,
5-[2-cyclopropyl-1-(2-fluorphenyl)-2-oxoethyl]-5,6,7,7a-tetrahydro-4H-thieno[3,2-c]pyridine-2-on,
C18H18FNO2S,
CS-O-15767,
CID11416277,
Prasugrel inactive metabolite (R-95913),
R-95913,
4-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxo-ethyl]-9-thia-4-azabicyclo[4.3.0]non-6-en-8-one,